YR, F., AA, C., AS, W., B, W., J, V., GC, M., . . . DR, S. (2018). Combination of anthracyclines and anti-CD47 therapy inhibit invasive breast cancer growth while preventing cardiac toxicity by regulation of autophagy. Breast cancer research and treatment, 172(1), 69. https://doi.org/10.1007/s10549-018-4884-x
Chicago Style (17th ed.) CitationYR, Feliz-Mosquea, et al. "Combination of Anthracyclines and Anti-CD47 Therapy Inhibit Invasive Breast Cancer Growth While Preventing Cardiac Toxicity by Regulation of Autophagy." Breast Cancer Research and Treatment 172, no. 1 (2018): 69. https://doi.org/10.1007/s10549-018-4884-x.
MLA (9th ed.) CitationYR, Feliz-Mosquea, et al. "Combination of Anthracyclines and Anti-CD47 Therapy Inhibit Invasive Breast Cancer Growth While Preventing Cardiac Toxicity by Regulation of Autophagy." Breast Cancer Research and Treatment, vol. 172, no. 1, 2018, p. 69, https://doi.org/10.1007/s10549-018-4884-x.